Pharmaceutical

60 Degrees and Yale to progress tafenoquin for babesiosis

60 Degrees has signed a patent licence agreement with Yale School of Medicine for tafenoquine development for babesiosis.

Apr 10, 2025 - 06:00
60 Degrees and Yale to progress tafenoquin for babesiosis
60 Degrees has signed a patent licence agreement with Yale School of Medicine for tafenoquine development for babesiosis.
Read the original article

Tags:

Previous Article

Beyond oncology: The expanding potential of cell and gene therapies

Next Article

Pharma CEOs warn EC President of “risk of exodus” to US

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

UK MHRA strengthens regulations on fluoroquinolone antibiotics

UK MHRA strengthens regulations on fluoroquinolone anti...

Jan 23, 2024

Clues from mice could help explain why women face a higher risk of autoimmune disorders

Clues from mice could help explain why women face a hig...

Feb 1, 2024

STAT+: Mayo Clinic partners with supercomputing startup Cerebras to build custom AI tools

STAT+: Mayo Clinic partners with supercomputing startup...

Jan 8, 2024